
Cassidy Bio
Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.
About
Cassidy Bio is an AI-powered company that designs genome editing systems, including guides and editors, by leveraging a genomic foundation model. Their specialized model turns years of trial-and-error into weeks of predictive, therapeutic-grade gene editing design, aiming to make gene editing medicines scalable, predictable, and accessible. They serve the field of gene editing therapeutic development by providing intelligence and predictive tools to accelerate the design process.
Key facts
At-a-glance profile data
- Website
- cassidybio.com
- Founded
- 2023
- Employees
- 15
- Total funding
- $20M
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 28 Jul 2025 | Undisclosed round | $8M | - |
| 1 May 2023 | Undisclosed round | $11M | Breakout Ventures |
| 1 May 2023 | Undisclosed round | $1M | - |
Tech stack
Detected on cassidybio.com, last scanned 27 Sept 2026. Run your own scan
- Analytics
- Google Tag Manager
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Cookie consent
- Cookiebot
Frequently asked
How much funding has Cassidy Bio raised?
Cassidy Bio has raised a total of $20M in funding.
How many employees does Cassidy Bio have?
Cassidy Bio has approximately 15 people on record.
